Nicotine polacrilex side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Nicotine polacrilex (nicotine polacrilex). Common side effects include drug ineffective among females and drug ineffective among males.
The phase IV clinical study is created by eHealthMe based on 6,411 reports from the FDA, and is updated regularly.
What is Nicotine Polacrilex?
Nicotine polacrilex has active ingredients of nicotine polacrilex. It is often used in quit smoking. eHealthMe is studying from 6,437 Nicotine polacrilex users. Check the latest studies of Nicotine polacrilex.
6,411 people who take Nicotine Polacrilex and have side effects are studied.
What are the common side effects of Nicotine polacrilex, by gender? *
What are the common side effects of Nicotine polacrilex, by age (0-1 to 60+)? *
What are the common side effects of Nicotine polacrilex, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Nicotine polacrilex?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on nicotine polacrilex (the active ingredients of Nicotine polacrilex) and Nicotine polacrilex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Nicotine polacrilex:
- Nicotine polacrilex (6,437 reports)
All Nicotine polacrilex side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Eliquis and Tylenol drug interactions for women aged 50-59 - 3 seconds ago
- Glipizide and Dyspepsia Aggravated for Women aged 60+ - 9 seconds ago
- Could Aleve cause Hepatotoxicity? - 13 seconds ago
- Could Mesalamine cause Abdominal Tenderness? - 20 seconds ago
- Benadryl and Wound Infection for Men aged 60+ - 22 seconds ago
- Itraconazole and Hallucination for Men aged 60+ - 22 seconds ago
- Itraconazole and Sensory Hallucinations for Men aged 60+ - 22 seconds ago
- Itraconazole and Hallucinations for Men aged 60+ - 23 seconds ago
- Could Seroquel cause Mood Swings? - 25 seconds ago
- Could Metoprolol Succinate cause Septic Shock? - 30 seconds ago